217 related articles for article (PubMed ID: 29996671)
1. Complex interaction between mutant HNRNPA1 and gE of varicella zoster virus in pathogenesis of multiple sclerosis.
Kattimani Y; Veerappa AM
Autoimmunity; 2018 Jun; 51(4):147-151. PubMed ID: 29996671
[TBL] [Abstract][Full Text] [Related]
2. Immunological evasion of immediate-early varicella zoster virus proteins.
Meysman P; Fedorov D; Van Tendeloo V; Ogunjimi B; Laukens K
Immunogenetics; 2016 Jul; 68(6-7):483-486. PubMed ID: 27020058
[TBL] [Abstract][Full Text] [Related]
3. Human T cells recognize multiple epitopes of an immediate early/tegument protein (IE62) and glycoprotein I of varicella zoster virus.
Bergen RE; Sharp M; Sanchez A; Judd AK; Arvin AM
Viral Immunol; 1991; 4(3):151-66. PubMed ID: 1725699
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical identification of varicella-zoster virus gene 63-encoded protein (IE63) and late (gE) protein on smears and cutaneous biopsies: implications for diagnostic use.
Nikkels AF; Debrus S; Sadzot-Delvaux C; Piette J; Rentier B; Piérard GE
J Med Virol; 1995 Dec; 47(4):342-7. PubMed ID: 8636701
[TBL] [Abstract][Full Text] [Related]
5. Dysregulated Glycoprotein B-Mediated Cell-Cell Fusion Disrupts Varicella-Zoster Virus and Host Gene Transcription during Infection.
Oliver SL; Yang E; Arvin AM
J Virol; 2017 Jan; 91(1):. PubMed ID: 27795423
[TBL] [Abstract][Full Text] [Related]
6. Varicella-zoster virus with a lost gE epitope: evidence for immunological pressure by the human antibody response.
Padilla JA; Grose C
Arch Virol Suppl; 2001; (17):27-39. PubMed ID: 11339548
[TBL] [Abstract][Full Text] [Related]
7. [VARICELLA ZOSTER VIRUS AND DISEASES OF CENTRAL NERVOUS SYSTEM VESSELS].
Kazanova AS; Lavrov VF; Zverev VV
Zh Mikrobiol Epidemiol Immunobiol; 2015; (3):106-16. PubMed ID: 26259280
[TBL] [Abstract][Full Text] [Related]
8. Cross-reactivity between myelin oligodendrocyte glycoprotein and human endogenous retrovirus W protein: nanotechnological evidence for the potential trigger of multiple sclerosis.
de Luca V; Martins Higa A; Malta Romano C; Pimenta Mambrini G; Peroni LA; Trivinho-Strixino F; Lima Leite F
Micron; 2019 May; 120():66-73. PubMed ID: 30802755
[TBL] [Abstract][Full Text] [Related]
9. Ability of yeast Ty-VLPs (virus-like particles) containing varicella-zoster virus (VZV)gE and assembly protein fragments to induce in vitro proliferation of human lymphocytes from VZV immune patients.
Welsh MD; Harper DR; Garcia-Valcarcel M; Fowler WJ; Aitken C; Jeffries DJ; Layton GT
J Med Virol; 1999 Sep; 59(1):78-83. PubMed ID: 10440812
[TBL] [Abstract][Full Text] [Related]
10. Stability of a varicella-zoster virus glycoprotein E epitope.
Vafai A; Forghani B; Kilpatrick D; Ling J; Shankar V
Arch Virol; 2000; 145(1):85-97. PubMed ID: 10664408
[TBL] [Abstract][Full Text] [Related]
11. Autoantibodies that recognize functional domains of hnRNPA1 implicate molecular mimicry in the pathogenesis of neurological disease.
Lee SM; Dunnavant FD; Jang H; Zunt J; Levin MC
Neurosci Lett; 2006 Jun; 401(1-2):188-93. PubMed ID: 16600502
[TBL] [Abstract][Full Text] [Related]
12. Varicella zoster virus glycoprotein C increases chemokine-mediated leukocyte migration.
González-Motos V; Jürgens C; Ritter B; Kropp KA; Durán V; Larsen O; Binz A; Ouwendijk WJD; Lenac Rovis T; Jonjic S; Verjans GMGM; Sodeik B; Krey T; Bauerfeind R; Schulz TF; Kaufer BB; Kalinke U; Proudfoot AEI; Rosenkilde MM; Viejo-Borbolla A
PLoS Pathog; 2017 May; 13(5):e1006346. PubMed ID: 28542541
[TBL] [Abstract][Full Text] [Related]
13. Neutralizing antibody responses induced by varicella-zoster virus gE and gB glycoproteins following infection, reactivation or immunization.
Haumont M; Jurdan M; Kangro H; Jacquet A; Massaer M; Deleersnyder V; Garcia L; Bosseloir A; Bruck C; Bollen A; Jacobs P
J Med Virol; 1997 Sep; 53(1):63-8. PubMed ID: 9298734
[TBL] [Abstract][Full Text] [Related]
14. The ORF61 Protein Encoded by Simian Varicella Virus and Varicella-Zoster Virus Inhibits NF-κB Signaling by Interfering with IκBα Degradation.
Whitmer T; Malouli D; Uebelhoer LS; DeFilippis VR; Früh K; Verweij MC
J Virol; 2015 Sep; 89(17):8687-700. PubMed ID: 26085158
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation.
Jacquet A; Haumont M; Massaer M; Garcia L; Mazzu P; Daminet V; Grégoire D; Jacobs P; Bollen A
Vaccine; 2002 Feb; 20(11-12):1593-602. PubMed ID: 11858867
[TBL] [Abstract][Full Text] [Related]
16. Multiple Sclerosis-Associated hnRNPA1 Mutations Alter hnRNPA1 Dynamics and Influence Stress Granule Formation.
Clarke JWE; Thibault PA; Salapa HE; Kim DE; Hutchinson C; Levin MC
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809384
[TBL] [Abstract][Full Text] [Related]
17. Identification of immunodominant regions and linear B cell epitopes of the gE envelope protein of varicella-zoster virus.
Fowler WJ; Garcia-Valcarcel M; Hill-Perkins MS; Murphy G; Harper DR; Jeffries DJ; Burns NR; Adams SE; Kingsman AJ; Layton GT
Virology; 1995 Dec; 214(2):531-40. PubMed ID: 8553555
[TBL] [Abstract][Full Text] [Related]
18. Clinical and molecular pathogenesis of varicella virus infection.
Gilden DH; Cohrs RJ; Mahalingam R
Viral Immunol; 2003; 16(3):243-58. PubMed ID: 14583142
[TBL] [Abstract][Full Text] [Related]
19. Coexpression of class I major histocompatibility antigen and viral RNA in central nervous system of mice infected with Theiler's virus: a model for multiple sclerosis.
Lindsley MD; Patick AK; Prayoonwiwat N; Rodriguez M
Mayo Clin Proc; 1992 Sep; 67(9):829-38. PubMed ID: 1434926
[TBL] [Abstract][Full Text] [Related]
20. Immune evasion as a pathogenic mechanism of varicella zoster virus.
Abendroth A; Arvin AM
Semin Immunol; 2001 Feb; 13(1):27-39. PubMed ID: 11289797
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
